Logo

Chinese University of Hong Kong Licenses Fluidigm's BioMark RT-PCR System

May 28, 2007
NEW YORK (GenomeWeb News) - Fluidigm said last week that the Department of Chemical Pathology at the Chinese University of Hong Kong has licensed its BioMark real-time PCR system.
 
Fluidigm said that the lab is using the system to study viruses associated with cancer, to detect somatic mutations in genes, and to develop gene expression profiles, among other molecular diagnostic research projects.
 
Financial terms of the agreement were not provided.

Breaking News
The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.